Olga A Aleshina, Kristina Zakurdaeva, Anastasia N Vasileva, Sergey K Dubov, Vitaly S Dubov, Vladimir I Vorobyev, Lev S Butaev, Alena M Sukhareva, Lubov V Gavrilova, Inessa Yu Toropova, Marina O Popova, Aleksandr A Siniaev, Aleksandr D Kulagin, Kamil D Kaplanov, Andrei A Petrenko, Oksana I Ochirova, Alina Karpova, Ekaterina Yu Chelysheva, Anna G Turkina, Margarita A Gurianova, Liubov S Al-Radi, Elena A Gilyazitdinova, Elena K Egorova, Yulia A Chabaeva, Sergey M Kulikov, Yulia V Sveshnikova, Mikhail A Kunst, Vasily Shuvaev, Anzhelika F Rakhmani, Olga L Panteleeva, Maria E Grishunina, Olga S Samoylova, Ekaterina Vorontsova, Daria V Baryshnikova, Elena N Parovichnikova
BACKGROUND: Patients with hematologic diseases are at higher risk of the SARS-CoV-2 infection and more severe clinical outcomes of the coronavirus disease. CHRONOS19 is an observational prospective cohort study with the aim to determine the short and longer-term clinical outcomes, risk factors for disease severity and mortality, and rates of postinfectious immunity in patients with malignant and nonmalignant hematologic diseases and COVID-19. PATIENTS AND METHODS: Overall, 666 patients were enrolled in the study, of which 626 were included in the final data analysis...
April 14, 2023: Clinical Lymphoma, Myeloma & Leukemia